Co-Authors
This is a "connection" page, showing publications co-authored by Syed Hasan and Muhammad Hadi.
Connection Strength
2.054
-
Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. Expert Opin Pharmacother. 2021 Feb; 22(2):229-240.
Score: 0.909
-
The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review. Expert Rev Anti Infect Ther. 2022 02; 20(2):211-229.
Score: 0.240
-
Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS-CoV-2 in the respiratory tract. Pharmacol Res Perspect. 2021 02; 9(1):e00698.
Score: 0.232
-
Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials? Int J Infect Dis. 2020 Dec; 101:107-120.
Score: 0.226
-
Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis. Am J Cardiovasc Drugs. 2020 Dec; 20(6):571-590.
Score: 0.226
-
Vitamin D Supplementation in Influenza and COVID-19 Infections Comment on: "Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths" Nutrients 2020, 12(4), 988. Nutrients. 2020 Jun 01; 12(6).
Score: 0.221